image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 3.1411
-2.75 %
$ 355 M
Market Cap
-0.89
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one DH stock under the worst case scenario is HIDDEN Compared to the current market price of 3.14 USD, Definitive Healthcare Corp. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one DH stock under the base case scenario is HIDDEN Compared to the current market price of 3.14 USD, Definitive Healthcare Corp. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one DH stock under the best case scenario is HIDDEN Compared to the current market price of 3.14 USD, Definitive Healthcare Corp. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
251 M REVENUE
12.92%
-330 M OPERATING INCOME
-1325.42%
-202 M NET INCOME
-809.40%
41.2 M OPERATING CASH FLOW
15.77%
-31.8 M INVESTING CASH FLOW
87.23%
-25.6 M FINANCING CASH FLOW
4.17%
62.7 M REVENUE
-1.63%
-225 M OPERATING INCOME
-7056.78%
-284 M NET INCOME
-32.74%
19.4 M OPERATING CASH FLOW
38.40%
8.96 M INVESTING CASH FLOW
-40.00%
-12.1 M FINANCING CASH FLOW
14.57%
Balance Sheet Definitive Healthcare Corp.
image
Current Assets 380 M
Cash & Short-Term Investments 308 M
Receivables 59.2 M
Other Current Assets 13.1 M
Non-Current Assets 1.43 B
Long-Term Investments 509 K
PP&E 14.1 M
Other Non-Current Assets 1.42 B
Current Liabilities 171 M
Accounts Payable 5.79 M
Short-Term Debt 16 M
Other Current Liabilities 149 M
Non-Current Liabilities 456 M
Long-Term Debt 252 M
Other Non-Current Liabilities 204 M
EFFICIENCY
Earnings Waterfall Definitive Healthcare Corp.
image
Revenue 251 M
Cost Of Revenue 47.5 M
Gross Profit 204 M
Operating Expenses 546 M
Operating Income -330 M
Other Expenses -127 M
Net Income -202 M
RATIOS
81.11% GROSS MARGIN
81.11%
-131.18% OPERATING MARGIN
-131.18%
-80.50% NET MARGIN
-80.50%
-23.50% ROE
-23.50%
-11.08% ROA
-11.08%
-18.70% ROIC
-18.70%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Definitive Healthcare Corp.
image
Net Income -202 M
Depreciation & Amortization 51.8 M
Capital Expenditures -2.98 M
Stock-Based Compensation 48.7 M
Change in Working Capital -30.4 M
Others 160 M
Free Cash Flow 38.2 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Definitive Healthcare Corp.
image
Wall Street analysts predict an average 1-year price target for DH of $6.31 , with forecasts ranging from a low of $4 to a high of $8 .
DH Lowest Price Target Wall Street Target
4 USD 27.34%
DH Average Price Target Wall Street Target
6.31 USD 100.96%
DH Highest Price Target Wall Street Target
8 USD 154.69%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Definitive Healthcare Corp.
image
Sold
0-3 MONTHS
212 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 months ago
Dec 03, 2024
Sell 212 K USD
Moschella William
Chief Product & Tech Officer
- 45000
4.7 USD
1 year ago
Aug 24, 2023
Sell 23 K USD
SEA VII Management, LLC
Director
- 2454
9.39 USD
1 year ago
Aug 24, 2023
Sell 39.5 K USD
SEA VII Management, LLC
Director
- 4202
9.39 USD
1 year ago
May 12, 2023
Sell 21 K USD
SEA VII Management, LLC
director, 10 percent owner:
- 2301
9.11 USD
1 year ago
May 12, 2023
Sell 35.9 K USD
SEA VII Management, LLC
director, 10 percent owner:
- 3939
9.11 USD
2 years ago
Feb 27, 2023
Sell 33.4 M USD
SEA VII Management, LLC
director, 10 percent owner:
- 3000000
11.12 USD
2 years ago
Nov 07, 2022
Bought 5.19 M USD
Krantz Jason Ronald
Director
+ 450000
11.54 USD
2 years ago
Aug 08, 2022
Sell 23.1 M USD
Spectrum Equity Associates VII, L.P.
director:
- 1016000
22.75 USD
2 years ago
Aug 08, 2022
Sell 5.89 M USD
Winn David Randall
Director
- 245277
24.025 USD
2 years ago
Aug 08, 2022
Sell 138 K USD
Winn David Randall
director:
- 5763
24.025 USD
2 years ago
May 10, 2022
Sell 283 K USD
Haywood Jeffrey Charles
director:
- 18315
15.46 USD
2 years ago
May 10, 2022
Sell 13.4 K USD
Spectrum Equity Associates VII, L.P.
director:
- 811
16.52 USD
3 years ago
Mar 03, 2022
Bought 50 K USD
Booth Richard Douglas
Chief Financial Officer
+ 2374.173
21.06 USD
3 years ago
Sep 17, 2021
Sell 1.69 M USD
SEA VII Management, LLC
director, 10 percent owner:
- 66857
25.3125 USD
7. News
DH or FFIV: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Internet - Software sector have probably already heard of Definitive Healthcare Corp. (DH) and F5 Networks (FFIV). But which of these two stocks presents investors with the better value opportunity right now? zacks.com - 1 week ago
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast FRAMINGHAM, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2024, on Thursday, February 27, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. globenewswire.com - 2 weeks ago
A Dive Into Definitive Healthcare Definitive Healthcare trades at a discount to the overall market based on P/E, and a new CEO with a focus on simplifying operations but faces declining profits and revenues. The company also has recently announced a new $100 billion stock buyback authorization and is seeing significant unlevered free cash flow. A first look at Definitive Healthcare follows in the paragraphs below. seekingalpha.com - 3 weeks ago
DH vs. FFIV: Which Stock Is the Better Value Option? Investors looking for stocks in the Internet - Software sector might want to consider either Definitive Healthcare Corp. (DH) or F5 Networks (FFIV). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 4 weeks ago
Definitive Healthcare (DH) Surges 8.4%: Is This an Indication of Further Gains? Definitive Healthcare (DH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. zacks.com - 1 month ago
Definitive Healthcare named a 2025 Best Places to Work in Boston by Built In FRAMINGHAM, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of Built In's 100 Best Places to Work in Boston, MA for 2025. The annual awards program includes companies of all sizes, from startups to large enterprises, and honors both remote-first employers as well as companies in large tech markets across the U.S. globenewswire.com - 1 month ago
Definitive Healthcare (DH) Moves to Buy: Rationale Behind the Upgrade Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com - 1 month ago
Down -5.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Definitive Healthcare (DH) Definitive Healthcare (DH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. zacks.com - 1 month ago
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 1 month ago
Definitive Healthcare to Present at the 27th Annual Needham Growth Conference FRAMINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and its Chief Financial Officer, Rick Booth, will present at the 27th Annual Needham Growth Conference. globenewswire.com - 1 month ago
DH vs. PRVA: Which Stock Is the Better Value Option? Investors with an interest in Medical Info Systems stocks have likely encountered both Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks presents investors with the better value opportunity right now? zacks.com - 2 months ago
Definitive Healthcare initiated with an Equal Weight at Stephens Stephens initiated coverage of Definitive Healthcare with an Equal Weight rating and $5 price target. Definitive has "an impressive collection of data assets that have attracted a marquee customer base," as well as a track record of expanding enterprise relationships, but this is all "still in early stages of coming together as a single, unified platform," the analyst tells investors. The firm thinks investors need to see multiple, firm data points supporting a return to growth before re-rating the stock higher from here, the analyst added. https://thefly.com - 2 months ago
8. Profile Summary

Definitive Healthcare Corp. DH

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 355 M
Dividend Yield 0.02%
Description Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Contact 550 Cochituate Road, Framingham, MA, 01701 https://www.definitivehc.com
IPO Date Sept. 15, 2021
Employees 950
Officers Mr. Kevin D. Coop Chief Executive Officer & Director Mr. Matthew Ruderman Chief Legal Officer & Secretary Mr. William Moschella Chief Product & Technology Officer Mr. Jason Ronald Krantz Founder & Executive Chairman Ms. Kate Marie Shamsuddin Jensen Chief Operating Officer Mr. Craig Hazenfield Chief People Officer